Antonio Nucum, DO
Psychiatry · Sterling Hts, MINPI 1164431540
Payments from drug & device makers
Across 761 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- Sunovion Pharmaceuticals Inc.$1K
- plus $6K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 156 | $2,161 |
| Otsuka America Pharmaceutical, Inc. | 82 | $1,937 |
| AbbVie(2 entities) | 91 | $1,325 |
| Johnson & Johnson | 68 | $1,297 |
| Alkermes, Inc. | 54 | $1,200 |
| Sunovion Pharmaceuticals Inc. | 59 | $1,045 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $860 |
| Neurocrine Biosciences, Inc. | 27 | $823 |
| Teva Pharmaceuticals USA, Inc. | 31 | $747 |
| Validus Pharmaceuticals LLC | 16 | $695 |
| Ironshore Pharmaceuticals Inc. | 25 | $660 |
| Corium, LLC | 31 | $653 |
| Vanda Pharmaceuticals Inc. | 20 | $422 |
| Supernus Pharmaceuticals, Inc. | 13 | $351 |
| Axsome Therapeutics, Inc. | 5 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Neos Therapeutics, LP | 6 | $104 |
| Avanir Pharmaceuticals, Inc. | 6 | $96 |
| E.r. Squibb & Sons, L.L.C. | 5 | $87 |
| Noven Therapeutics, LLC | 4 | $85 |
| Collegium Pharmaceutical, Inc. | 3 | $81 |
| Idorsia Pharmaceuticals US Inc | 3 | $57 |
| Indivior Inc. | 2 | $56 |
| Shire North American Group Inc | 4 | $54 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Bausch Health US, LLC | 2 | $28 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $19 |
How this compares
$15,278 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Sterling Hts
- Andreas SidiropoulasDetroit$2.8M
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Brian MickeyAnn Arbor$490K
- Sagar ParikhAnn Arbor$331K
- Robert LagrouClarkston$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.